Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 811-823

  Li, Yi Ping ^a,b,c   Ramirez, Santseharay ^a,b   Mikkelsen, Lotte ^a,b   Bukh, Jens ^a,b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADAPTIVE IMMUNITY; ANTIGEN DETECTION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; SEQUENCE ANALYSIS; VIRUS ASSEMBLY; VIRUS CULTURE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; ADAPTATION; CELL LINE; GENETICS; GENOTYPE; HEPACIVIRUS; LIVER CELL; MUTATION; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY; VIRUS GENE; VIRUS LOAD;

HEPATITIS C VIRUS;

ADAPTATION, BIOLOGICAL; CELL LINE; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATOCYTES; HUMANS; MUTATION; VIRAL LOAD; VIRUS CULTIVATION; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84919431426     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02877-14     Document Type: Article

References (57)

1. Moradpour D, Penin F, Rice CM. 2007. Replication of hepatitis C virus. Nat Rev Microbiol 5:453-463. http://dx.doi.org/10.1038/nrmicro1645.
2. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton J T, Simmonds P. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59:318-327. http://dx.doi.org/10.1002/hep.26744.
3. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky J M, Penin F, Sablon E, Shin I, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973. http://dx.doi.org/10.1002/hep.20819.
4. Bukh J, Purcell RH, Miller RH. 1993. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 90:8234-8238. http://dx.doi.org/10.1073/pnas.90.17.8234.
5. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM. 2012. Antiviral strategies in hepatitis C virus infection. J Hepatol 56(Suppl 1):S88-S100.
6. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362. http://dx.doi.org/10.1126/science.2523562.
7. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796. http://dx.doi.org/10.1038/nm1268.
8. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102:9294-9299. http://dx.doi.org/10.1073/pnas.0503596102.
9. Li YP, Ramirez S, Jensen SB, Purcell RH, Gottwein J M, Bukh J. 2012. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc Natl Acad Sci USA 109:19757-19762. http://dx.doi.org/10.1073/pnas.1218260109.
10. Li YP, Ramirez S, Gottwein J M, Scheel TK, Mikkelsen L, Purcell RH, Bukh J. 2012. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Proc Natl Acad Sci USA 109:E1101-E1110. http://dx.doi.org/10.1073/pnas.1203829109.
11. Ramirez S, Li YP, Jensen SB, Pedersen J, Gottwein J M, Bukh J. 2014. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors. Hepatology 59:395-407. http://dx.doi.org/10.1002/hep.26660.
12. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. 2006. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103:2310-2315. http://dx.doi.org/10.1073/pnas.0510727103.
13. Pietschmann T, Zayas M, Meuleman P, Long G, Appel N, Koutsoudakis G, Kallis S, Leroux-Roels G, Lohmann V, Bartenschlager R. 2009. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog 5:e1000475. http://dx.doi.org/10.1371/journal.ppat.1000475.
14. Date T, Kato T, Kato J, Takahashi H, Morikawa K, Akazawa D, Murayama A, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Wakita T. 2012. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone. J Virol 86:10805-10820. http://dx.doi.org/10.1128/JVI.07235-11.
15. Lu J, Xiang Y, Tao W, Li Q, Wang N, Gao Y, Xiang X, Xie Q, Zhong J. 2014. Anovel strategy to develop a robust infectious hepatitisCvirus cell culture system directly from a clinical isolate. J Virol 88:1484-1491. http://dx.doi.org/10.1128/JVI.02929-13.
16. Choo QL, Richman KH, Han J H, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455. http://dx.doi.org/10.1073/pnas.88.6.2451.
17. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941. http://dx.doi.org/10.1126/science.282.5390.938.
18. Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby MJ, Ou J. 2001. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20:3840-3848. http://dx.doi.org/10.1093/emboj/20.14.3840.
19. Stamataki Z, Coates S, Evans MJ, Wininger M, Crawford K, Dong C, Fong YL, Chien D, Abrignani S, Balfe P, Rice CM, McKeating JA, Houghton M. 2007. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 25: 7773-7784. http://dx.doi.org/10.1016/j.vaccine.2007.08.053.
20. Meunier JC, Gottwein JM, Houghton M, Russell RS, Emerson SU, Bukh J, Purcell RH. 2011. Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus. J Infect Dis 204:1186-1190. http://dx.doi.org/10.1093/infdis/jir511.
21. Stamataki Z, Coates S, Abrignani S, Houghton M, McKeating JA. 2011. Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains. J Infect Dis 204:811-813. http://dx.doi.org/10.1093/infdis/jir399.
22. Law JL, Chen C, Wong J, Hockman D, Santer DM, Frey SE, Belshe RB, Wakita T, Bukh J, Jones CT, Rice CM, Abrignani S, Tyrrell DL, Houghton M. 2013. A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. PLoS One 8:e59776. http://dx.doi.org/10.1371/journal.pone.0059776.
23. Kuiken C, Combet C, Bukh J, Shin I, Deleage G, Mizokami M, Richardson R, Sablon E, Yusim K, Pawlotsky JM, Simmonds P. 2006. A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes. Hepatology 44:1355-1361. http://dx.doi.org/10.1002/hep.21377.
24. Yanagi M, Purcell RH, Emerson SU, Bukh J. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A 94:8738-8743. http://dx.doi.org/10.1073/pnas.94.16.8738.
25. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574. http://dx.doi.org/10.1126/science.277.5325.570.
26. Nakajima N, Hijikata M, Yoshikura H, Shimizu YK. 1996. Characterization of long-term cultures of hepatitis C virus. J Virol 70:3325-3329.
27. Shimizu YK, Igarashi H, Kiyohara T, Shapiro M, Wong DC, Purcell RH, Yoshikura H. 1998. Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol 79:1383-1386.
28. Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T, Patel A, Kohn LD, Liang TJ. 2002. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 76:9335-9344. http://dx.doi.org/10.1128/JVI.76.18.9335-9344.2002.
29. Bartosch B, Dubuisson J, Cosset FL. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633-642. http://dx.doi.org/10.1084/jem.20021756.
30. Blight KJ, McKeating JA, Marcotrigiano J, Rice CM. 2003. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77:3181-3190. http://dx.doi.org/10.1128/JVI.77.5.3181-3190.2003.
31. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-1581. http://dx.doi.org/10.1126/science.1113329.
32. Kanda T, Basu A, Steele R, Wakita T, Ryerse JS, Ray R, Ray RB. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol 80:4633-4639. http://dx.doi.org/10.1128/JVI.80.9.4633-4639.2006.
33. Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, Wakita T, Liang TJ. 2007. Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol 81:4405-4411. http://dx.doi.org/10.1128/JVI.02334-06.
34. Heller T, Saito S, Auerbach J, Williams T, Moreen TR, Jazwinski A, Cruz B, Jeurkar N, Sapp R, Luo G, Liang TJ. 2005. An in vitro model of hepatitis C virion production. Proc Natl Acad Sci USA 102:2579-2583. http://dx.doi.org/10.1073/pnas.0409666102.
35. Shimakami T, Welsch C, Yamane D, McGivern DR, Yi M, Zeuzem S, Lemon SM. 2011. Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus. Gastroenterology 140:667-675. http://dx.doi.org/10.1053/j.gastro.2010.10.056.
36. Lanford RE, Lee H, Chavez D, Guerra B, Brasky KM. 2001. Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence. J Gen Virol 82:1291-1297.
37. Gottwein JM, Scheel TK, Hoegh AM, Lademann JB, Eugen-Olsen J, Lisby G, Bukh J. 2007. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133:1614-1626. http://dx.doi.org/10.1053/j.gastro.2007.08.005.
38. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM. 2005. Complete replication of hepatitis C virus in cell culture. Science 309:623-626. http://dx.doi.org/10.1126/science.1114016.
39. Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J. 2011. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR. Proc Natl Acad Sci USA 108:4991-4996. http://dx.doi.org/10.1073/pnas.1016606108.
40. Scheel TK, Gottwein JM, Mikkelsen LS, Jensen TB, Bukh J. 2011. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha. Gastroenterology 140:1032-1042. http://dx.doi.org/10.1053/j.gastro.2010.11.036.
41. Gottwein JM, Scheel TK, Callendret B, Li YP, Eccleston HB, Engle RE, Govindarajan S, Satterfield W, Purcell RH, Walker CM, Bukh J. 2010. Novel infectious cDNA clones of hepatitisCvirus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J Virol 84:5277-5293. http://dx.doi.org/10.1128/JVI.02667-09.
42. Bukh J, Thimme R, Meunier JC, Faulk K, Spangenberg HC, Chang KM, Satterfield W, Chisari FV, Purcell RH. 2008. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain. J Virol 82:8183-8195. http://dx.doi.org/10.1128/JVI.00142-08.
43. Russell RS, Meunier JC, Takikawa S, Faulk K, Engle RE, Bukh J, Purcell RH, Emerson SU. 2008. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc Natl Acad Sci USA 105:4370-4375. http://dx.doi.org/10.1073/pnas.0800422105.
44. Gottwein JM, Jensen SB, Serre SB, Ghanem L, Scheel TK, Jensen TB, Krarup H, Uzcategui N, Mikkelsen LS, Bukh J. 2013. Adapted J6/JFH1-based hepatitis C virus recombinants with genotype-specific NS4A show similar efficacy to lead protease inhibitors, interferon-alpha and a putative NS4A inhibitor. Antimicrob Agents Chemother 57:6034-6049. http://dx.doi.org/10.1128/AAC.01176-13.
45. Prentoe J, Serre SB, Ramirez S, Nicosia A, Gottwein JM, Bukh J. 2014. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus. J Virol 88: 1725-1739. http://dx.doi.org/10.1128/JVI.02017-13.
46. Li YP, Ramirez S, Humes D, Jensen SB, Gottwein JM, Bukh J. 2014. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors. Gastroenterology 146: 812-821. http://dx.doi.org/10.1053/j.gastro.2013.11.009.
47. Sakai A, Takikawa S, Thimme R, Meunier JC, Spangenberg HC, Govindarajan S, Farci P, Emerson SU, Chisari FV, Purcell RH, Bukh J. 2007. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells. J Virol 81:7208-7219. http://dx.doi.org/10.1128/JVI.01774-06.
48. Weiner AJ, Paliard X, Selby MJ, Medina-Selby A, Coit D, Nguyen S, Kansopon J, Arian CL, Ng P, Tucker J, Lee CT, Polakos NK, Han J, Wong S, Lu HH, Rosenberg S, Brasky KM, Chien D, Kuo G, Houghton M. 2001. Intrahepatic genetic inoculation of hepatitisCvirusRNAconfers cross-protective immunity. J Virol 75:7142-7148. http://dx.doi.org/10.1128/JVI.75.15.7142-7148.2001.
49. Murayama A, Weng L, Date T, Akazawa D, Tian X, Suzuki T, Kato T, Tanaka Y, Mizokami M, Wakita T, Toyoda T. 2010. RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog 6:e1000885. http://dx.doi.org/10.1371/journal.ppat.1000885.
50. Yi M, Hu F, Joyce M, Saxena V, Welsch C, Chavez D, Guerra B, Yamane D, Veselenak R, Pyles R, Walker CM, Tyrrell L, Bourne N, Lanford RE, Lemon SM. 2014. Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol 88:3678-3694. http://dx.doi.org/10.1128/JVI.03540-13.
51. Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R. 2002. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 99:14416-14421. http://dx.doi.org/10.1073/pnas.212532699.
52. Yamane D, McGivern DR, Wauthier E, Yi M, Madden VJ, Welsch C, Antes I, Wen Y, Chugh PE, McGee CE, Widman DG, Misumi I, Bandyopadhyay S, Kim S, Shimakami T, Oikawa T, Whitmire JK, Heise MT, Dittmer DP, Kao CC, Pitson SM, Merrill AH, Jr, Reid LM, Lemon SM. 2014. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med 20:927-935. http://dx.doi.org/10.1038/nm.3610.
53. Scheel TK, Gottwein JM, Carlsen TH, Li YP, Jensen TB, Spengler U, Weis N, Bukh J. 2011. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 85:2891-2906. http://dx.doi.org/10.1128/JVI.01605-10.
54. Scheel TK, Prentoe J, Carlsen TH, Mikkelsen LS, Gottwein JM, Bukh J. 2012. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems. PLoS Pathog 8:e1002696. http://dx.doi.org/10.1371/journal.ppat.1002696.
55. Bressanelli S, Tomei L, Rey FA, De Francesco R. 2002. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J Virol 76:3482-3492. http://dx.doi.org/10.1128/JVI.76.7.3482-3492.2002.
56. Cai Z, Yi M, Zhang C, Luo G. 2005. Mutagenesis analysis of the rGTPspecific binding site of hepatitis C virus RNA-dependent RNA polymerase. J Virol 79:11607-11617. http://dx.doi.org/10.1128/JVI.79.18.11607-11617.2005.
57. Schmitt M, Scrima N, Radujkovic D, Caillet-Saguy C, Simister PC, Friebe P, Wicht O, Klein R, Bartenschlager R, Lohmann V, Bressanelli S. 2011. A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes. J Virol 85:2565-2581. http://dx.doi.org/10.1128/JVI.02177-10.